BioNTech’s Founders Will Leave to Start New Firm With mRNA Focus

2026-03-10 - 10:53

(Bloomberg) — BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine. Read More